Solar solutions: Agrivoltaics offer array of options for farmland use

The process of combining agricultural production and solar panels on the same farmland, known as agrivoltaics, has seen a great leap in Cornell research activity. 

Backyard poultry at risk when migrating mallards stop to rest

Knowing the duration and timing of when migrating mallard ducks – natural carriers of avian influenza – stop and rest can help predict the probability that they will infect backyard poultry flocks.

Professor’s new novel imagines a U.S. without Texas

Charlie Green, a senior lecturer in the Department of Literatures in English, published his new novel “The Shah of Texas,” on Feb. 18.

Astronomer Anna Ho and team win Scialog award

The research will look at data from supermassive black holes residing in the centers of distant galaxies.

Around Cornell

Islet-transplantation procedure shows promises against T1 diabetes

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine investigators.

New study advances acoustic monitoring of endangered whale

A Cornell-led team has developed a method to estimate North Atlantic right whale numbers using underwater microphones and machine learning, potentially offering a safer and more cost-effective way to monitor this endangered species.

Solar solutions: Bio-inspired approach creates bespoke photovoltaics

An interdisciplinary team of Cornell researchers is developing HelioSkin, an aesthetically appealing solar-collection fabric that is inspired by the biological mechanisms that enable plants to bend toward the sun.

Struggling men hurt noncollege women’s marriage prospects

Concern that college-educated women will struggle to find “marriageable” partners is misplaced, finds new research co-authored by a Cornell economist.

New therapy may effectively control HIV in Uganda

A multinational, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.